SMILAGENIN ACETATE
CAS No. 4947-75-5
SMILAGENIN ACETATE( Nsc15488 )
Catalog No. M19805 CAS No. 4947-75-5
Smilagenin acetate is a sapogenin derivative extracted from patent US20030004147A1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 113 | In Stock |
|
10MG | 169 | In Stock |
|
25MG | 286 | In Stock |
|
50MG | 433 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSMILAGENIN ACETATE
-
NoteResearch use only, not for human use.
-
Brief DescriptionSmilagenin acetate is a sapogenin derivative extracted from patent US20030004147A1.
-
DescriptionSmilagenin acetate is a sapogenin derivative extracted from patent US20030004147A1. Smilagenin acetate increases the expression of acetylcholine m2 receptors and can be used for the research of dementia.(In Vitro):Smilagenin acetate increases the expression of m2 receptors on CHO cells transfected with DNA for the m2 receptor.
-
In VitroSmilagenin acetate increases the expression of m2 receptors on CHO cells transfected with DNA for the m2 receptor.
-
In Vivo——
-
SynonymsNsc15488
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaNeurological Disease
-
IndicationAlzheimer's disease; Amyotrophic lateral sclerosis; Glaucoma; Parkinson's disease
Chemical Information
-
CAS Number4947-75-5
-
Formula Weight458.67
-
Molecular FormulaC29H46O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@H]5C[C@H](CC[C@]5(C)[C@H]4CC[C@]23C)OC(C)=O)O[C@]11CC[C@@H](C)CO1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
YM 511
aromatase (CYP19) inhibitor.
-
Pinostilbene
Pinostilbene obviously attenuates the phosphorylation of c-Jun and JNK triggered by 6-OHDA.
-
TFMB-(R)-2-HG
TFMB-(R)-2-HG is a carcinogenic factor in Acute myeloid leukemia (AML). TFMB-(R)-2-HG impairs SCF ER-Hoxb8 cell differentiation in response to estrogen withdrawal.